Stocks Buzz: Micron Technology, Inc. (NASDAQ:MU), Abbott Laboratories (NYSE:ABT)

On Wednesday, Shares of Micron Technology, Inc.(NASDAQ:MU), subtract -0.56% and closed at $17.70 in the last trading session. The last trading range of the stock ranges between $17.28 and $18.33. Micron Technology, Inc. provides semiconductor systems worldwide. It operates in four segments: Compute and Networking Business Unit, Mobile Business Unit, Storage Business Unit, and Embedded Business Unit. The company offers DDR4 and DDR3 DRAM products for computers, servers, networking devices, communications equipment, consumer electronics, automotive, and industrial applications; mobile low-power DRAM products for mobile phones, tablets, embedded, computers, and other mobile consumer device applications; DDR2 DRAM, DDR DRAM, GDDR5 DRAM, SDRAM, reduced latency DRAM, and pseudo-static DRAM products for use in networking devices, servers, consumer electronics, communications equipment, computer peripherals, automotive and industrial applications, and computer memory upgrades; and HMC semiconductor memory devices for use in networking and computing applications. It also provides NAND Flash products, which are electrically re-writeable, non-volatile semiconductor memory devices; client solid-state drives (SSDs) for notebooks, desktops, workstations, and other consumer applications; enterprise SSDs for server and storage applications; managed multi-chip package products; digital media products, counting flash memory cards and JumpDrive products under the Lexar brand name. In addition, the company manufactures products that are sold under other brand names; and resells flash memory products that are purchased from other NAND Flash suppliers. Further, it provides NOR Flash memory products, which are electrically re-writeable, semiconductor memory devices for wireless and embedded applications.

Abbott Laboratories(NYSE:ABT), jumped 1.52% and closed at $42.74 in the last trading session. The last trading range of the stock ranges between $42.33 and $42.81. The company’s Market capitalization is $62.16 Billion with the total Outstanding Shares of 1.47 Billion. Abbott Laboratories manufactures and sells health care products worldwide. The company’s Established Pharmaceutical Products segment offers branded generic pharmaceuticals to treat pancreatic exocrine insufficiency; irritable bowel syndrome or biliary spasm; intrahepatic cholestasis or depressive symptoms; gynecological disorders; hormone replacement therapy; dyslipidemia; hypertension; hypothyroidism; Ménière’s disease and vestibular vertigo; pain, fever, and inflammation; migraines; anti-infective clarithromycin; and influenza vaccines, in addition to to regulate physiological rhythm of the colon. Its Diagnostic Products segment provides immunoassay and clinical chemistry systems; assays used to screen and/or diagnosis cancer, cardiac, drugs of abuse, fertility, infectious diseases, and therapeutic drug monitoring; hematology systems and reagents; diagnostic systems and cartridges; instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents; genomic-based tests; informatics and automation solutions; and instrument used to identify infection-causing pathogens. The company’s Nutritional Products segment provides pediatric and adult nutritional products, such as prepared infant and follow-on formulas. Its Vascular Products segment offers coronary, endovascular, vessel closure, and structural heart devices to treat vascular disease. The company also provides blood and flash glucose monitoring systems, counting test strips, sensors, data administration decision software, and accessories for people with diabetes; and medical devices for the eye, such as cataract and LASIK surgery, contact lens care, and dry eye products.

Leave a Reply

Your email address will not be published. Required fields are marked *